FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

400575004: Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2005. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1768496017 Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1779805013 Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge Is a Product containing insulin aspart (medicinal product) false Inferred relationship Some
    Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Human insulin false Inferred relationship Some
    Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pancreatic hormone false Inferred relationship Some
    Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start